Aranesp Hematopoietic Agent Darbepoetin Alfa in Polysorbate Solution 25 mcg / 0.4 mL Subcutaneous or Intravenous Injection Prefilled Syringe 0.4 mL , 4/Box , Amgen 55513005704
TERMS & CONDITIONS FOR PURCHASING INJECTABLES & MEDICATIONS :
1- REGULATIONS ON PURCHASE OF INJECTABLES & MEDICATIONS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE.
2- INJECTABLES & MEDICATIONS WOULD BE SOLD ONLY TO QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , DENTAL OFFICES , HEALTH CARE PROVIDERS , .... ) WITH VALID MEDICAL LICENSE.
3- ORDERS INCLUDING PURCHSE OF INJECTABLES & MEDICATIONS WOULD BE PROCESSED AFTER VERIFICATION OF PURCHASER'S VALID MEDICAL LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )
Manufacturer # | 55513005704 |
Brand | Aranesp® |
Manufacturer | Amgen Inc |
Application | Hematopoietic Agent |
Container Type | Prefilled Syringe |
Dosage Form | Injection |
Generic Drug Code | 97064 |
Generic Drug Name | Darbepoetin Alfa in Polysorbate Solution |
NDC Number | 55513-0057-04 |
Storage Requirements | Requires Refrigeration |
Strength | 25 mcg / 0.4 mL |
Type | Subcutaneous or Intravenous |
UNSPSC Code | 51131507 |
Volume | 0.4 mL |
Features
- SingleJect® prefilled syringe with 27 gauge x 1/2 inch needle and UltraSafe® needle guard
- Each 1 mL contains 0.05 mg polysorbate 80, and is formulated at pH 6.2 ± 0.2 with 2.12 mg sodium phosphate monobasic monohydrate, 0.66 mg sodium phosphate dibasic anhydrous, and 8.18 mg sodium chloride in Water for Injection, USP (to 1 mL)